SCHEMBL4277901

SCHEMBL4277901

CCCCCCCCCCOC(=O)C(CC)(CCCC)CCCCCCCC

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.50
CYP4A11 Q02928 1/20 0.50
NAAA Q02083 1/20 0.48
EPHX1 P07099 1/20 0.46
TSHR P16473 3/20 0.44
HCAR2 Q8TDS4 1/20 0.42
RAD52 P43351 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
MEN1 O00255 1/20 0.41
MAPT P10636 1/20 0.41
KMT2A Q03164 1/20 0.41
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
FAAH O00519 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
ACHE P22303 6/20 0.41
LPAR1 Q92633 1/20 0.40
LPAR3 Q9UBY5 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27518613 1.00 CYP4F2 (0.50) CYP4F2CYP4A11NAAAEPHX1TSHR
SCHEMBL27653255 1.00 CYP4F2 (0.50) CYP4F2CYP4A11NAAAEPHX1TSHR
SCHEMBL27855522 1.00 CYP4F2 (0.50) CYP4F2CYP4A11NAAAEPHX1TSHR
SCHEMBL27872170 1.00 CYP4F2 (0.50) CYP4F2CYP4A11NAAAEPHX1TSHR
SCHEMBL27855525 1.00 CYP4F2 (0.50) CYP4F2CYP4A11NAAAEPHX1TSHR
SCHEMBL611991 1.00 CYP4F2 (0.50) CYP4F2CYP4A11NAAAEPHX1TSHR
SCHEMBL27526740 1.00 CYP4F2 (0.50) CYP4F2CYP4A11NAAAEPHX1TSHR
SCHEMBL28297772 0.98 CYP4F2 (0.51) CYP4F2CYP4A11NAAAEPHX1TSHR
SCHEMBL28774056 0.96 CYP4F2 (0.53) CYP4F2CYP4A11NAAAEPHX1TSHR
SCHEMBL26959289 0.95 NAAA (0.47) CYP4F2CYP4A11NAAAEPHX1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090257968-A1 Gels containing anionic surfactants and coupling agents WALTON RICHARD 2009-10-15 US disclosed
US-20050220832-A1 Gels containing metallic soaps and coupling agents WALTON RICHARD 2005-10-06 US disclosed
EP-1141167-A4 ELECTRICAL INSULATING FLUID GREAT LAKES CHEMICAL EUROP (CH) 2002-06-26 EP disclosed
EP-1141167-A1 ELECTRICAL INSULATING FLUID Great Lakes Chemical (Europe) GmbH (CH) 2001-10-10 EP disclosed
WO-2000034409-A1 ELECTRICAL INSULATING FLUID GREAT LAKES CHEMICAL (EUROPE) GMBH (CH) 2000-06-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050220832-A1 Gels containing metallic soaps and coupling agents MSN, S100P, STMN1 CYP4F2 3322/4885CYP4A11 4097/4885NAAA 433/4885
US-20090257968-A1 Gels containing anionic surfactants and coupling agents RAB5IF, ANXA4, ANXA11 CYP4F2 4767/4885CYP4A11 4157/4885NAAA 424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.